Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NQO2 | P16083 | 5/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | G6PD | P11413 | 1/20 | 0.36 |
| ▸ | PKM | P14618 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25513983 | 0.94 | NQO2 (0.33) | NQO2NPC1LMNAPOLBMAPT | |
| SCHEMBL12124204 | 0.94 | NQO2 (0.33) | NQO2NPC1LMNAPOLBMAPT | |
| SCHEMBL20000005 | 0.92 | NPC1 (0.30) | NQO2NPC1LMNAPOLBMAPT | |
| SCHEMBL13250932 | 0.88 | FTO (0.33) | MAPT | |
| SCHEMBL19398982 | 0.85 | KDM4E (0.36) | NQO2MAPT | |
| SCHEMBL15987275 | 0.85 | KDM4E (0.36) | NQO2MAPT | |
| SCHEMBL19999999 | 0.80 | AMY1A (0.33) | NQO2NPC1LMNAPOLBMAPT | |
| SCHEMBL12124175 | 0.79 | — | — | |
| SCHEMBL13250933 | 0.79 | — | — | |
| SCHEMBL10001255 | 0.79 | FTO (0.40) | MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11660575-B2 | Reactive inhibition of pore structure collapse during pyrolytic formation of carbon molecular sieves | ExxonMobil Technology and Engineering Company (US) | 2023-05-30 | — | — | US | disclosed |
| US-20160367948-A1 | CROSSLINKED POLYMER, METHOD FOR PRODUCING THE SAME, MOLECULAR SIEVE COMPOSITION AND MATERIAL SEPARATION MEMBRANES | KYOTO UNIVERSITY (JP) | 2016-12-22 | — | — | US | disclosed |
| US-9244008-B2 | Surface plasmon resonance sensor element and sensor including the same | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2016-01-26 | — | — | US | disclosed |
| US-8395086-B2 | Heater device | QINETIQ LIMITED (GB) | 2013-03-12 | — | — | US | disclosed |
| US-8137979-B2 | Preconcentrator device | QINETIQ LIMITED (GB) | 2012-03-20 | — | — | US | disclosed |
| US-8056732-B2 | Microporous polymer material | THE UNIVERSITY OF MANCHESTER (GB) | 2011-11-15 | — | — | US | disclosed |
| US-20100304112-A1 | MICROPOROUS POLYMER MATERIAL | THE UNIVERSITY OF MANCHESTER (GB) | 2010-12-02 | — | — | US | disclosed |
| US-20100144049-A1 | PRECONCENTRATOR DEVICE INCORPORATING A POLYMER OF INTRINSIC MICROPOROSITY | QINETIQ LIMITED (GB) | 2010-06-10 | — | — | US | disclosed |
| US-20100130796-A1 | HEATER SUITABLE FOR USE IN A PRECONCENTRATOR DEVICE | QINETIQ LIMITED (GB) | 2010-05-27 | — | — | US | disclosed |
| US-7690514-B2 | Microporous polymer material | THE UNIVERSITY OF MANCHESTER (GB) | 2010-04-06 | — | — | US | disclosed |
| US-20090211336-A1 | HEATER DEVICE | QINETIQ LIMITED (GB) | 2009-08-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100130796-A1 | HEATER SUITABLE FOR USE IN A PRECONCENTRATOR DEVICE | PIEZO1, PIM1, PIM3 | NQO2 1337/4885NPC1 2542/4885LMNA 1695/4885 |
| US-11660575-B2 | Reactive inhibition of pore structure collapse during pyrolytic formation of carbon molecular sieves | PRF1, STOM, CYCS | NQO2 3738/4885NPC1 2013/4885LMNA 371/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.